Author
Listed:
- Hirotoshi Watanabe
- Takeshi Morimoto
- Masahiro Natsuaki
- Yutaka Furukawa
- Yoshihisa Nakagawa
- Kazushige Kadota
- Kyohei Yamaji
- Kenji Ando
- Satoshi Shizuta
- Hiroki Shiomi
- Tomohisa Tada
- Junichi Tazaki
- Yoshihiro Kato
- Mamoru Hayano
- Mitsuru Abe
- Takashi Tamura
- Manabu Shirotani
- Shinji Miki
- Mitsuo Matsuda
- Mamoru Takahashi
- Katsuhisa Ishii
- Masaru Tanaka
- Takeshi Aoyama
- Osamu Doi
- Ryuichi Hattori
- Masayuki Kato
- Satoru Suwa
- Akinori Takizawa
- Yoshiki Takatsu
- Eiji Shinoda
- Hiroshi Eizawa
- Teruki Takeda
- Jong-Dae Lee
- Moriaki Inoko
- Hisao Ogawa
- Shuichi Hamasaki
- Minoru Horie
- Ryuji Nohara
- Hirofumi Kambara
- Hisayoshi Fujiwara
- Kazuaki Mitsudo
- Masakiyo Nobuyoshi
- Toru Kita
- Adnan Kastrati
- Takeshi Kimura
- CREDO-Kyoto PCI/CABG registry cohort-2 investigators
Abstract
Relation of antiplatelet therapy (APT) discontinuation with the risk of serious cardiovascular events has not been fully addressed yet. This study is aimed to evaluate the risk of ischemic event after APT discontinuation based on long-term APT status of large cohort. In the CREDO-Kyoto Registry Cohort-2 enrolling 15939 consecutive patients undergoing first coronary revascularization, 10470 patients underwent percutaneous coronary intervention either with bare-metal stents (BMS) only (N=5392) or sirolimus-eluting stents (SES) only (N=5078). Proportions of patients taking dual-APT were 67.3% versus 33.4% at 1-year, and 48.7% versus 24.3% at 5-year in the SES and BMS strata, respectively. We evaluated daily APT status (dual-, single- and no-APT) and linked the adverse events to the APT status just 1-day before the events. No-APT as compared with dual- or single-APT was associated with significantly higher risk for stent thrombosis (ST) beyond 1-month after SES implantation (cumulative incidence rates beyond 1-month: 1.23 versus 0.15/0.29, P
Suggested Citation
Hirotoshi Watanabe & Takeshi Morimoto & Masahiro Natsuaki & Yutaka Furukawa & Yoshihisa Nakagawa & Kazushige Kadota & Kyohei Yamaji & Kenji Ando & Satoshi Shizuta & Hiroki Shiomi & Tomohisa Tada & Jun, 2015.
"Antiplatelet Therapy Discontinuation and the Risk of Serious Cardiovascular Events after Coronary Stenting: Observations from the CREDO-Kyoto Registry Cohort-2,"
PLOS ONE, Public Library of Science, vol. 10(4), pages 1-23, April.
Handle:
RePEc:plo:pone00:0124314
DOI: 10.1371/journal.pone.0124314
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:plo:pone00:0124314. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: plosone (email available below). General contact details of provider: https://journals.plos.org/plosone/ .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.